TNF and infection: Of all biologics, most data are available for anti-TNF and indeed confirm the theoretical concerns of increased infectious complications in these elderly patients: in an Italian multicentric cohort of 95 patients aged above 65 years, 11% developed severe infections, and 10% of these died because of them [21].